NDC 51316-600 – Guaifenesin and Dextromethorphan Hydrobromide
Guaifenesin 1200 mg/1; Dextromethorphan Hydrobromide 60 mg/1 · Tablet, Extended Release · Oral
Product NDC51316-600
Product details
- Brand name
- Guaifenesin and Dextromethorphan Hydrobromide
- Generic name
- Guaifenesin and Dextromethorphan Hydrobromide
- Labeler
- CVS PHARMACY, INC
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA214781
- Marketed since
- April 19, 2022
- Listing expires
- December 31, 2027
- Pharmacologic class
- Expectorant; Sigma-1 Agonist; Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Active ingredients
- Guaifenesin 1200 mg/1
- Dextromethorphan Hydrobromide 60 mg/1
Uses, dosage, side effects and warnings for Guaifenesin and Dextromethorphan Hydrobromide →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 51316-600-70 | 5 BLISTER PACK in 1 CARTON (51316-600-70) / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK | Apr 19, 2022 |
Other Guaifenesin and Dextromethorphan Hydrobromide products
- 72162-2277 Dextromethorphan Hydrobromide 10 mg/5mL; Guaifenesin 100 mg/5mL · Syrup · Bryant Ranch Prepack
- 57631-013 Guaifenesin 400 mg/1; Dextromethorphan Hydrobromide 20 mg/1 · Tablet · InvaTech Pharma Solutions LLC
- 58657-504 Dextromethorphan Hydrobromide 10 mg/5mL; Guaifenesin 100 mg/5mL · Syrup · Method Pharmaceuticals
- 58657-505 Dextromethorphan Hydrobromide 10 mg/5mL; Guaifenesin 100 mg/5mL · Syrup · Method Pharmaceuticals